1-855-378-42281-855-378-4228
One of the out-patient rehabilitation alternatives for people in Mcnary who are struggling with opioid abuse and addiction is called opioid maintenance therapy. Some clinics and doctors are authorized to administer certain meds to opioid addicted individuals, many of which are opioids themselves and are addiction. In low enough doses however, the individual does not experience high feelings and also doesn't experience severe cravings and isn't in opioid withdrawal. Methadone is the first medication used for this reason, but there are a few more choices currently to select from.
Methadone is an opiate and is meant to be taken at an outpatient medical center licensed to dispense the drug, that is taken on a daily basis in liquid or pill form. The cost of the drug is about one hundred and fifty dolloars a month. Buprenorphine is also an opioid based drug, and is in pill form often taken every other day. But unlike Methadone which can only be administered in well-regulated medical centers, Buprenorphine can be and is prescribed and administered in doctor's offices. The price monthly of buprenorphine is about three hundred dollars a month for the generic of the med. There is also a type of buprenorphine containing the drug naloxone, which is a drug that blocks the effects of opioids. Someone taking this version of the drug, also known as Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken every day, and is priced about $450 per month. Naltrexone is an additional drug taken in opioid maintenance therapy, but unlike the other medications mentioned here it's an opioid blocker and isn't an opiate. There is an option to take this drug as a monthly shot, which is called Vivitrol. As an opioid blocker, it prevents an individual from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 monthly.
For All Alcohol and Drug Treatment Centers In Mcnary, Click Here.
